There have been 50 recent insider transactions recorded for Cardiff Oncology, Inc. (CRDF), including 47 buys and 1 sell. Total insider buying was valued at $16.4M and total insider selling at $743.75K.
Notable insiders with recent activity include Mohindru Mani, Lindsay Brigitte Ute, Pace Gary W. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CRDF
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Mohindru Mani |
Chief Executive Officer |
RSU Award |
600,000 |
$1.62 |
$972K |
968,766 |
| 2026-02-17 |
Mohindru Mani |
Interim CEO |
RSU Award |
200,000 |
$1.56 |
$312K |
368,766 |
| 2026-02-13 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
RSU Award |
200,000 |
$1.60 |
$320K |
1,025,334 |
| 2026-01-27 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
Unknown |
166,320 |
$3.58 |
$595.43K |
- |
| 2025-07-30 |
Pace Gary W |
Director |
Informative Buy |
275,000 |
$2.45 |
$673.75K |
1,330,676 |
| 2025-06-26 |
Pace Gary W |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
Armitage James O |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
White Lale |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
158,681 |
| 2025-06-26 |
Markin Rodney S |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
222,865 |
| 2025-06-26 |
Tannenbaum Renee P |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-26 |
Mohindru Mani |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-16 |
Sidhu Roger |
Chief Medical Officer |
Unknown |
600,000 |
$3.86 |
$2.32M |
- |
| 2025-03-11 |
Levine James E. |
Chief Financial Officer |
RSU Award |
332,621 |
$3.58 |
$1.19M |
1,295,117 |
| 2025-03-11 |
Erlander Mark |
Chief Executive Officer |
RSU Award |
758,400 |
$3.58 |
$2.72M |
2,925,098 |
| 2025-03-11 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU Award |
150,000 |
$3.58 |
$537K |
780,008 |
| 2025-03-11 |
Smeal Tod |
Chief Scientific Officer |
RSU Award |
332,621 |
$3.58 |
$1.19M |
979,805 |
| 2024-12-18 |
Levine James E. |
Chief Financial Officer |
Informative Buy |
2,400 |
$5.00 |
$12K |
67,716 |
| 2024-12-17 |
Levine James E. |
Chief Financial Officer |
Informative Buy |
2,752 |
$5.42 |
$14.91K |
65,316 |
| 2024-12-16 |
Levine James E. |
Chief Financial Officer |
Informative Buy |
2,564 |
$3.83 |
$9.82K |
62,564 |
| 2024-12-12 |
Tannenbaum Renee P |
Director |
Informative Buy |
10,000 |
$3.42 |
$34.22K |
20,000 |
| 2024-12-11 |
Pace Gary W |
Director |
Informative Buy |
350,115 |
$2.60 |
$910.3K |
1,047,876 |
| 2024-06-27 |
Pace Gary W |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Armitage James O |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Markin Rodney S |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
182,027 |
| 2024-06-27 |
Tannenbaum Renee P |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-06-27 |
White Lale |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Mohindru Mani |
Director |
RSU Award |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-03-07 |
Levine James E. |
Chief Financial Officer |
RSU Award |
205,008 |
$3.51 |
$719.58K |
962,496 |
| 2024-03-07 |
Erlander Mark |
Chief Executive Officer |
RSU Award |
510,000 |
$3.51 |
$1.79M |
2,170,310 |
| 2024-03-07 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU Award |
205,008 |
$3.51 |
$719.58K |
630,008 |
| 2024-03-07 |
Smeal Tod |
Chief Scientific Officer |
RSU Award |
205,008 |
$3.51 |
$719.58K |
647,184 |
| 2023-12-19 |
Pace Gary W |
Director |
Informative Buy |
30,000 |
$1.37 |
$41.1K |
697,761 |
| 2023-11-10 |
Pace Gary W |
Director |
Informative Buy |
22,950 |
$0.98 |
$22.49K |
667,761 |
| 2023-06-15 |
Pace Gary W |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Armitage James O |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Markin Rodney S |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
152,327 |
| 2023-06-15 |
Tannenbaum Renee P |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-06-15 |
White Lale |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Mohindru Mani |
Director |
RSU Award |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-03-15 |
Levine James E. |
Chief Financial Officer |
RSU Award |
197,472 |
$1.72 |
$339.65K |
757,488 |
| 2023-03-15 |
Erlander Mark |
Chief Executive Officer |
RSU Award |
482,064 |
$1.72 |
$829.15K |
1,664,477 |
| 2023-03-15 |
Kelemen Vicki |
Exec. VP and COO |
RSU Award |
125,520 |
$1.72 |
$215.89K |
698,304 |
| 2023-03-15 |
Smeal Tod |
Chief Scientific Officer |
RSU Award |
167,088 |
$1.72 |
$287.39K |
442,176 |
| 2023-01-30 |
Kabbinavar Fairooz |
Chief Medical Officer |
Disposition |
425,000 |
$1.75 |
$743.75K |
- |
| 2022-11-25 |
Erlander Mark |
Chief Executive Officer |
Informative Buy |
10,000 |
$1.43 |
$14.3K |
24,481 |
| 2022-09-19 |
White Lale |
Director |
Informative Buy |
15,000 |
$1.64 |
$24.53K |
113,788 |
| 2022-09-16 |
Levine James E. |
Chief Financial Officer |
Informative Buy |
30,000 |
$1.56 |
$46.71K |
60,000 |
| 2022-09-16 |
Armitage James O |
Director |
Informative Buy |
13,000 |
$1.56 |
$20.23K |
13,000 |
| 2022-09-15 |
Pace Gary W |
Director |
Informative Buy |
150,000 |
$1.71 |
$256.5K |
644,811 |
| 2022-09-15 |
Tannenbaum Renee P |
Director |
Informative Buy |
6,400 |
$1.72 |
$10.98K |
6,400 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
